explore -WSS

explore

author：Wikipedia 2025-09-28 02:30:55 - browse：69784

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Stanford president to resign after investigation of research

WSS

DOJ, FTC to increase scrutiny of all types of health care mergers

DOJ, FTC to increase scrutiny of all types of health care mergers

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Clinicians often fail to acknowledge the pain caused by long Covid

'Reaching a detente': STAT's Helen Branswell on covering Covid

Ebola public health emergency is over, WHO declares

Wikipedia

explore

Sign up for Morning Rounds

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Medical students need to learn the potent medicine of empathy

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ebola public health emergency is over, WHO declares

Drug repurposing or repositioning? The language matters

The world needs the new pandemic treaty

Malaria cases in Florida and Texas: Here’s what you need to know

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Medicare details structure of new drug price negotiation program

Seattle police shoot person suspected in downtown stabbing

explore

How dance can help health care workers heal from trauma

Celebrate National Dole Whip Day for 3 days this week at Disney

Seattle police shoot person suspected in downtown stabbing

Congress: Prevent baby formula shortages by passing a new bill

New research sheds light on how often breast cancer is overdiagnosed

Congress: Prevent baby formula shortages by passing a new bill

focus

focus

explore

focus